Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Harpoon Therapeutics Inc (HARP)
Harpoon Therapeutics Inc (HARP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Harpoon Therapeutics Inc 131 OYSTER POINT BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 USA

P: 650-443-7400

Description:

Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company developing a novel class of T cell engagers which harness the power of the body's immune system to treat patients suffering from cancer and other diseases. Using its proprietary Tri-specific T cell Activating Construct(TM) platform, they are developing a pipeline of novel T cell engagers, focused on the treatment of solid tumors and hematologic malignancies. Harpoon Therapeutics Inc. is based in San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 24,830
Enterprise Value, $K -110,270
Shares Outstanding, K 33,107
Annual Sales, $ 23,650 K
Annual Net Income, $ -116,720 K
Last Quarter Sales, $ 13,620 K
Last Quarter Net Income, $ -11,640 K
60-Month Beta 1.57
% of Insider Shareholders 13.00%
% of Institutional Shareholders 65.52%
Float, K 28,803
% Float 87.00%
Short Volume Ratio 0.40

Growth:

1-Year Return -83.87%
3-Year Return -93.61%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.35 on 11/14/22
Next Earnings Date 03/23/23
Earnings Per Share ttm -2.16
EPS Growth vs. Prev Qtr 33.96%
EPS Growth vs. Prev Year 31.37%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

HARP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -198.21%
Return-on-Assets % -59.01%
Profit Margin % -493.53
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 0.77
Price/Cash Flow N/A
Price/Book 1.47
Book Value/Share 0.51
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar